Express News | JP Morgan Maintains Overweight on Olema Pharmaceuticals, Lowers Price Target to $31
Express News | Olema Pharmaceuticals Inc : JP Morgan Cuts Target Price to $31 From $33
Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $30 Price Target
Olema Pharmaceuticals Analyst Ratings
Buy Rating Reaffirmed for Olema Pharmaceuticals Amid Promising Breast Cancer Treatment Advances and Strong Financials
Buy Rating Affirmed for Olema Pharmaceuticals Amidst Promising Clinical Developments and Strategic Collaborations
Olema Pharmaceuticals GAAP EPS of -$0.54 Beats by $0.01
Olema Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Express News | Olema Oncology Q2 Basic EPS USD -0.54 Vs. IBES Estimate USD -0.55
Express News | Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Express News | Olema Oncology Q2 Operating Expenses USD 33.53 Million
Express News | Olema Oncology Q2 Net Income USD -30.382 Million
Express News | Olema Oncology Q2 Income From Operations USD -33.53 Million
Insider Sellers Might Regret Selling Olema Pharmaceuticals Shares at a Lower Price Than Current Market Value
Olema Pharmaceuticals(OLMA.US) Director Sells US$215.4K in Common Stock
Express News | Olema Pharmaceuticals: Amendment Increases Aggregate Principal Amount of Loan Facility to up to $100 Mln
Express News | Olema Pharmaceuticals: Got Into First Amendment to Loan & Security Agreement
Form 144 | Olema Pharmaceuticals(OLMA.US) Director Proposes to Sell 215.35K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $Olema Pharmaceuticals(OLMA.US)$ Director Harmon Cyrus intends to sell 20,000 shares of its common stock on Jun 28, with a total market value of approximately $215.35K.
Olema Pharmaceuticals(OLMA.US) Director Sells US$17.45 Million in Common Stock